Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia

Exclusion Criteria

• •Unable to understand the details and requirements of the study (at the discretion of the PI)
• •Female participants who are pregnant or planning to become pregnant
• •Presence of implanted electrical medical devices (i.e. pacemaker)
• •Currently taking medication intended to treat neurocognitive impairment (i.e. stimulants) or medications prescribed for seizure management
• •History of skin irritation or other issues during stimulation of inner ear
• •Currently utilizing a technological intervention for a sleep disorder (e.g. CPAP)
• •Medications and behavioral practices (white noise, night-time yoga, etc) are acceptable as long as the insomnia is persistent.
• •History of a contraindicated health condition including:
• •Syncope (CTCAE \>2)
• •Cardiac dysrhythmia (CTCAE \>2)
• •Vascular Disease (CTCAE \>2)
• •Coronary Artery Disease (CTCAE \>2)
• •Active contraindicated heath condition including:
• •Cranial Nerve Disorder (CTCAE \>2)
• •Neuropathy (Cranial Nerves) (CTCAE \>2)
• •Neuralgia (Cranial Nerves) (CTCAE \>2)
• •Overt Cerebrovascular Accident (CTCAE \>2)
• •Seizures (Any in most recent 1 year
• •Currently enrolled or participating in any other neurostimulation or neuromodulation ancillary research studies